Central role of hemoglobin degradation in mechanisms of action of 4- aminoquinolines, quinoline methanols, and phenanthrene methanols

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 11, 1998, Pages 2973-2977

  Mungthin, Mathirut ^a   Bray, Patrick G ^a   Ridley, Robert G ^b   Ward, Stephen A ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOQUINOLINE DERIVATIVE; AMODIAQUINE; ANTIMALARIAL AGENT; CHLOROQUINE; CYSTEINE PROTEINASE INHIBITOR; HALOFANTRINE; HEMOGLOBIN; MEFLOQUINE; PHENANTHRENE DERIVATIVE; PRIMAQUINE; QUININE; QUINOLINE DERIVATIVE; RO 40 4388; UNCLASSIFIED DRUG;

ANTIMALARIAL ACTIVITY; ARTICLE; DRUG MECHANISM; DRUG SCREENING; HEMOGLOBIN DETERMINATION; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 0031753042     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.11.2973     Document Type: Article

References (50)

1. Asawamahasakda, W., S. Ittarat, C. C. Chang, P. McElroy, and S. R. Meshnick. 1994. Effects of antimalarials and proteinase inhibitors on plasmodial haemozoin production. Mol. Biochem. Parasitol. 67:183-191.
2. Bailly, E., R. Jambou, J. Savel, and G. Jaureguiberry. 1992. Plasmodium falciparum: differential sensitivity in vitro to E-64 (cysteine protease inhibitor) and Pepstatin A (aspartyl protease inhibitor). J. Protozool. 39:593-599.
3. Balasubramanian, D., C. Mohan Roa, and B. Panjipan. 1984. The malaria parasite monitored by photoacoustic spectroscopy. Science 223:828-830.
4. Berenbaum, M. C. 1978. A method for testing for synergy with any number of agents. J. Infect. Dis. 137:122-130.
5. Bray, P. G., M. Mungthin, R. G. Ridley, and S. A. Ward. 1998. Access to hacmatin: the basis of chloroquine resistance. Mol. Pharmacol. 54:170-179.
6. Chevli, R., and C. D. Fitsch. 1982. The antimalarial drug mefloquine binds to membrane phospholipids. Antimicrob. Agents Chemother. 21:581-586.
7. Chou, A. C., R. Chevli, and C. D. Fitch. 1980. Ferriprotoporphyrin IX fulfils the criteria for identification as the chloroquine receptor of malaria parasites. Biochemistry 19:1543-1549.
8. Cohen, S., K. Phifer, and K. Yielding. 1964. Complex formation between chloroquine and ferrihaemic acid in vitro, and its effect on the antimalarial action of chloroquine. Nature 202:805-806.
9. Desjardins, R. E., C. J. Canfield, J. D. Haynes, and J. D. Chulay. 1979. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob. Agents Chemother. 16:710-718.
10. Desneves, J., G. Thorn, A. Berman, D. Galatis, N. La Greca, J. Sinding, M. Foley, L. W. Deady, A. F. Cowman, and L. Tilley. 1996. Photoaffinity labelling of mefloquine-binding proteins in human serum, uninfected erythrocytes and Plasmodium falciparum-infected erythrocytes. Mol. Biochem. Parasitol. 82: 181-194.
11. Dorn, A., R. Stoffel, H. Matile, A. Bubendorf, and R. G. Ridley. 1995. Malarial haemozoin/β-haematin supports haem polymerization in the absence of protein. Nature 374:269-271.
12. Dorn, A., S. R. Vippagunta, H. Matile, C. Jaquet, J. L. Vennerstrom, and R. G. Ridley. 1998. An assessment of drug-haematin binding as a mechanism for inhibition of haematin polymerisation by quinoline antimalarials. Biochem. Pharmacol. 55:727-736.
13. Fitch, C. D. 1983. Mode of action of antimalarial drugs, p. 222-232. In D. Evered and J. Whelan (ed.), Malaria and the red cell - 1983. Ciba Foundation symposium. Pitman, London, United Kingdom.
14. Foley, M., and L. Tilley. 1997. Quinoline antimalarials: mechanisms of action and resistance. Int. J. Parasitol. 27:231-240.
15. Francis, S. E., I. Y. Gluzman, A. Oksman, D. Banerjee, and D. E. Goldberg. 1996. Characterization of native falcipain, an enzyme involved in Plasmodium falciparum hemoglobin degradation. Mol. Biochem. Parasitol. 83:189-200.
16. Gluzman, I. Y., S. E. Francis, A. Oksman, C. E. Smith, K. L. Duffin, and D. E. Goldberg. 1994. Order and specificity of the Plasmodium falciparum haemoglobin degradation pathway. J. Clin. Invest. 93:1602-1608.
17. Goldberg, D. E., A. F. G. Slater, R. Beavis, B. Chait, A. Cerami, and G. B. Henderson. 1991. Haemoglobin degradation in the human malaria pathogen Plasmodium falciparum: a catabolic pathway initiated by a specific aspartic protease. J. Exp. Med. 173:961-969.
18. Goldberg, D. E., and A. F. G. Slater. 1992. The pathway of hemoglobin degradation in malaria parasites. Parasitol. Today 8:280-283.
19. Hawley, S. R., P. G. Bray, M. Mungthin, J. D. Atkinson, P. M. O'Neill, and S. A. Ward. 1998. Relationship between antimalarial drug activity, accumulation, and inhibition of heme polymerization in Plasmodium falciparum in vitro. Antimicrob. Agents Chemother. 42:682-686.
20. Jacob, G. H., M. Aikawa, W. K. Milhous, and J. R. Rabbege. 1987. An ultrastructural study of the effects of mefloquine on malaria parasites. Am. J. Trop. Med. Hyg. 36:9-14.
21. Jensen, J. B., and W. Trager. 1977. Plasmodium falciparum in culture: use of outdated erythrocytes and description of the candle-jar method. J. Parasitol. 63:883-886.
22. Knowles, G., W. L. Davidson, D. Jolley, and M. P. Alpers. 1984. The relationship between the in vitro response of Plasmodium falciparum to chloroquine, quinine and mefloquine. Trans. R. Soc. Trop. Med. Hyg. 78:146-150.
23. Lambros, C., and J. P. Vandenburg. 1979. Synchronisation of Plasmodium fulciparum erythrocyte stages in culture. J. Parasitol. 65:418-420.
24. Macomber, P. B., H. Sprinz, and A. J. Tousimis. 1967. Morphological effects of chloroquine on Plasmodium berghei in mice. Nature 214:937-934.
25. Moon, R. P., L. Tyas, U. Certa, K. Rupp, D. Bur, C. Jaquet, H. Matile, H. Loetscher, F. Grueninger-Leitch, J. Kay, B. M. Dunn, C. Bern, and R. G. Ridley. 1997. Expression and characterization of plasmepsin 1 from Plasmodium falciparum. Eur. J. Biochem. 244:552-560.
26. Mu, J. Y., Z. H. Israili, and P. G. Dayton. 1975. Studies of the disposition and metabolism of mefloquine HCl (WR 142490), a quinolinemethanol antimalarial, in the rat. Limited studies with an analog, WR 30090. Drug Metab. Dispos. 3:198-210.
27. Olliaro, P. L., F. Castelli, S. Caligaris, P. Druihe, and G. Carosi. 1989. Ultrastructure of Plasmodium falciparum in vitro. II. Morphological patterns of different quinolines' effects. Microbiologica 12:15-28.
28. Perrin, D. D. 1965. Dissociate constants of organic bases in aqueous solution, p. 531. Butterworth & Co., London, United Kingdom.
29. Peters, W. 1970. Chemotherapy and drug resistance in malaria, p. 1-22 Academic Press, London, United Kingdom.
30. Peters, W., R. E. Howells, J. Portus, B. L. Robinson, S. Thomas, and D. C. Warhurst. 1977. The chemotherapy of rodent malaria. XXVII. Studies on mefloquine (WR 142490). Ann. Trop. Med. Parasitol. 71:407-418.
31. Peters, W. 1987. Chemotherapy and drug resistance in malaria, 2nd ed., p. 1-18. Academic Press, London, United Kingdom.
32. Raynes, K., M. Foley, L. Tilly, and L. W. Deady. 1996. Novel bisquinoline antimalarials: synthesis, antimalarial activity and inhibition of haem polymerisation. Biochem. Pharmacol. 52:551-559.
33. Ridley, R. G. 1997. Haemoglobin degradation and haem polymerization as antimalarial drug targets. J. Pharm. Pharmacol. 49(Suppl. 2):43-48.
34. Ridley, R. G., A. Dorn, S. R. Vippagunta, and J. L. Vennerstrom. 1997. Haematin (haem) polymerization and its inhibition by quinoline antimalarials. Ann. Trop. Med. Parasitol. 91:559-566.
35. Rosenthal, P. J., J. H. McKerrow, M. Aikawa, H. Nagasawa, and J. H. Leech. 1988. A malarial cysteine protease is necessary for haemoglobin degradation by Plasmodium falciparum. J. Clin. Investig. 82:1560-1566.
36. Rosenthal, P. J. 1995. Plasmodium falciparum: effects of proteinase inhibitors on globin hydrolysis by culture malaria parasites. Exp. Parasitol. 80:272-281.
37. 14C-amino acids by malaria (Plasmodium lophurae). Int. J. Biochem. 1:635-637.
38. Slater, A. F. G., and A. Cerami. 1992. Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites. Nature 355:167-169.
39. Slater, A. F. G. 1993. Chloroquine: mechanism of drug action and resistance in Plasmodium falciparum. Pharmacol. Ther. 57:203-255.
40. Sowunmi, A., A. M. J. Oduola, L. A. Salako, O. A. Ogundahunsi, O. J. Laoye, and O. Walker. 1992. The relationship between the response of Plasmodium falciparum malaria to mefloquine in African children and its sensitivity in vitro. Trans. R. Soc. Trop. Med. Hyg. 86:368-371.
41. Steck, E. A. 1972. The chemotherapy of protozoan diseases, vol. III, section 4. Walter Reed Army Institute of Research, Washington, D.C.
42. Sullivan, D. J., I. Y. Gluzman, D. G. Russell, and D. E. Goldberg. 1996. On the molecular mechanism of chloroquine's antimalarial action. Proc. Natl. Acad. Sci. USA 93:11865-11870.
43. Theakston, R. D. G., K. A. Fletcher, and B. G. Maegraith. 1970. The use of electron microscope autoradiography for examining the uptake and degradation of haemoglobin by Plasmodium falciparum. Ann. Trop. Med. Parasitol. 64:63-71.
44. Van der Kaay, H. J., W. H. Wernsdorfer, and F. M. Froeling. 1985. In vitro response of Plasmodium falciparum to mefloquine: studies conducted in West and East-Africa. Ann. Soc. Belge Med. Trop. 65(Suppl. 2):147-153.
45. Ward, S. A., P. G. Bray, and S. R. Hawley. 1997. Quinoline resistance mechanisms in Plasmodium falciparum: the debate goes on. Parasitology 114:S125-S136.
46. Warhurst, D. C., and D. J. Hockley. 1967. Mode of action of chloroquine on Plasmodium berghei and Plasmodium cynomolgi. Nature 214:935-936.
47. Warhurst, D. C. 1981. The quinine-haemin interaction and its relationship to antimalarial activity. Biochem. Pharmacol. 30:3323-3327.
48. Warhurst, D. C. 1987. Antimalarial interaction with ferriprotoporphyrin IX monomer and its relationship to activity of blood schizonticides. Ann. Trop. Med. Parasitol. 81:65-67.
49. Wernsdorfer, W. H., B. Landgraf, G. Wiedermann, and H. Kollaritsch. 1994. Inverse correlation of sensitivity in-vitro of Plasmodium falciparum to chloroquine and mefloquine in Ghana. Trans. R. Soc. Trop. Med. Hyg. 88:443-444.
50. Yuthavong, Y., B. Panijpan, P. Ruenwongsa, and W. Sirawaraporn. 1985. Biochemical aspects of drug action and resistance in malaria parasites. Southeast Asian J. Trop. Med. Public Health 16:459-472.